HYPITAT-I试验对荷兰产科管理和结局的影响
该研究利用荷兰2000-2014年全国围产期登记数据,比较HYPITAT-I试验前后(2000-2005年与2008-2014年)妊娠期高血压或子痫前期足月孕妇的引产率、分娩方式及母婴结局。结果显示引产率从51.1%升至64.2%,孕产妇死亡和围产儿死亡均下降,参与试验医院的引产率上升和高血压并发症减少更为明显。
要点
- HDP组引产率由试验前51.1%升至试验后64.2%(RR 1.26,95%CI 1.24-1.27)。
- HDP组孕产妇死亡由0.022%降至0.004%(RR 0.20,95%CI 0.06-0.70)。
- HDP组围产儿死亡由0.49%降至0.27%(RR 0.54,95%CI 0.45-0.65),主要归因于胎儿死亡减少。
核心结论
- HYPITAT-I试验之后,荷兰足月妊娠合并妊娠期高血压疾病者的引产率升高,产科结局改善。
研究设计与样本
- 基于荷兰全国围产期登记2000-2014年数据的前后对比研究,HDP组143 749例,参照组1 649 510例。
- HYPITAT-I试验于2005至2008年间开展,研究比较试验前(2000-2005年)与试验后(2008-2014年)两个时期。
- 研究还区分参与与未参与HYPITAT-I试验的医院进行比较。
主要发现
- HDP组引产率从试验前51.1%升至试验后64.2%(RR 1.26,95%CI 1.24-1.27)。
- HDP组孕产妇死亡率从试验前0.022%降至试验后0.004%(RR 0.20,95%CI 0.06-0.70)。
- HDP组围产儿死亡率从0.49%降至0.27%(RR 0.54,95%CI 0.45-0.65),主要归因于胎儿死亡减少。
- 参与HYPITAT-I试验的医院引产率上升和高血压并发症减少均较未参与医院更为明显。
- 试验后参照组引产率亦上升4.6个百分点,但HDP组上升13.1个百分点,相对增幅显著更大(交互作用P < 0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Hypertension and Preeclampsia Intervention Trial At near Term-I (HYPITAT-I) randomized controlled trial showed that, in women with gestational hypertension or mild pre-eclampsia at term, induction of labor, compared with expectant management, was associated with improved maternal outcome without compromising neonatal outcome. The aim of the current study was to evaluate the impact of these findings on obstetric management and maternal and perinatal outcomes in The Netherlands. METHODS: We retrieved data for the period 2000-2014 from the Dutch National Perinatal Registry, including 143 749 women with gestational hypertension or pre-eclampsia and a singleton fetus in cephalic presentation, delivered between 36 + 0 and 40 + 6 weeks of gestation (hypertensive disorder of pregnancy (HDP) group). Pregnant women without HDP were used as the reference group (n = 1 649 510). The HYPITAT-I trial was conducted between 2005 and 2008. To study the impact of HYPITAT-I, we compared rate of induction of labor, mode of delivery and maternal and perinatal outcomes in the periods before (2000-2005) and after (2008-2014) the trial. We also differentiated between hospitals that participated in HYPITAT-I and those that did not. RESULTS: In the HDP group, the rate of induction of labor increased from 51.1% before the HYPITAT-I trial to 64.2% after it (relative risk (RR), 1.26; 95% CI, 1.24-1.27). Maternal mortality decreased from 0.022% before the trial to 0.004% after it (RR, 0.20; 95% CI, 0.06-0.70) and perinatal death decreased from 0.49% to 0.27% (RR, 0.54; 95% CI, 0.45-0.65), which was attributable mostly to a decrease in fetal death. Both the increase in induction rate and the reduction in hypertensive complications were more pronounced in hospitals that participated in the HYPITAT-I trial than in those that did not. Following HYPITAT-I, the rate of induction of labor also increased (by 4.6 percentage points) in the reference group; however, the relative increase in the HDP group (13.1 percentage points) was significantly greater (P < 0.001 for the interaction). The reduction in maternal and perinatal deaths did not differ significantly between the HDP and reference groups. There was a decreased incidence of placental abruption in both HDP and reference groups, which was significantly greater in the HDP than in the reference group (P < 0.001 for the interaction). There was also an increased incidence of emergency Cesarean section in both HDP and reference groups; however, this change was significantly greater in the reference than in the HDP group (P < 0.001 for the interaction). CONCLUSION: Following the HYPITAT-I trial, there was a higher rate of induction of labor and improved obstetric outcome in term pregnancies complicated by HDP in The Netherlands. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
- de Sonnaville CMW, Hukkelhoven CW, Vlemmix F, et al. Impact of Hypertension and Preeclampsia Intervention Trial At Near Term-I (HYPITAT-I) on obstetric management and outcome in The Netherlands. Ultrasound Obstet Gynecol. 2019. PMID: 31486156. doi:10.1002/uog.20417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。